Remodulin® to Oral Treprostinil Transition
NCT01588405
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
UT-15C SR
Sponsor
United Therapeutics